Ajanta Pharma Ltd.
Fundamentals
- Market cap
- ₹39,735 cr
- P/E
- 37.63×
- ROE
- 23.33%
- Debt / equity
- 0.05
- Div yield
- 0.86%
- 52-week range
- 2329.90 — 3314.90
Ajanta Pharma Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 6 notes on Ajanta Pharma Ltd.
July 2026
- 03 Jul 26 · 11:15 AM IST Lead Lead · Credit · Large cap
Ajanta Pharma promoters pledge 13.5% equity to back ₹3,873 cr outside debt
Three promoter entities have encumbered all their holdings, securing debentures of two unrelated private companies. The full scale and purpose are revealed for the first time, raising invocation risk for shareholders.
- 03 Jul 26 · 10:32 AM IST Brief Brief · Credit · Large cap
Ajanta Pharma promoter pledges 10.06 lakh shares; encumbered stake at 10.83%
The incremental 0.80% of equity is below the materiality threshold, but it adds to a flurry of promoter actions in June. Loan terms undisclosed.
June 2026
- 19 Jun 26 · 2:27 PM IST Brief Brief · Credit · Large cap
Ajanta Pharma promoter trust releases 23.26 lakh pledged shares
Ravi Agrawal Trust cuts encumbered stake to 2.75% from 4.61%, citing excess pledge. The move trims total promoter group encumbrance to about 15% and follows a ₹1,046 cr share sale earlier this month.
- 15 Jun 26 · 11:14 AM IST Brief Brief · Credit · Large cap
Ajanta Pharma promoter pledges additional 0.89% stake to RBL Bank
The latest pledge, along with a 2.2% pledge two days ago, brings total encumbered promoter holdings to 10.05%. The moves follow a ₹1,046 cr stake sale on June 9.
- 09 Jun 26 · 3:42 PM IST Lead Lead · Large cap
Ajanta Pharma promoter sells 2.76% stake for about ₹1,046 cr
Ravi Agrawal Trust cut the promoter group's holding from 13% to 10.24% in open-market trades on June 9.
- 09 Jun 26 · 10:22 AM IST Lead Lead · Credit · Large cap
Ajanta Pharma promoters just borrowed against another 2.2% of the company.
Gabs Investments pledged 27.7 lakh shares for a new loan, pushing the group's total pledged stake to 13.9% of equity.